People's Justice

Case trackerActive

GLP-1 drugs, sight loss and possible claims Updates

Updated Oct 4, 2026

Sudden sight loss after a GLP-1 drug? Seek eye care right away.

Register interest

From the record

Latest updates

  1. DATE

    WHAT HAPPENED

    JPML creates the GLP-1 vision-loss MDL — No. 3163

    SOURCE

    jpml.uscourts.gov

  2. DATE

    WHAT HAPPENED

    Harvard study in JAMA Ophthalmology links semaglutide to NAION

    SOURCE

    pubmed.ncbi.nlm.nih.gov

Stay informed

Get free updates about GLP-1 drugs, sight loss and possible claims

No phone call required. We will email you about relevant court filings, settlements, or important deadlines.

By submitting, you agree to receive email updates about this case. You can unsubscribe anytime. This is not legal advice, and we are not a law firm.

Sources

  1. JPML MDL3163 transfer order, December15,2025JPML MDL3163 transfer order, December15,2025 · court
  2. MDL3163 Case Management Order12, July2,2026MDL3163 Case Management Order12, July2,2026 · court
  3. MDL3163 Case Management Order14, August27,2026MDL3163 Case Management Order14, August27,2026 · court
  4. JPML actions pending report, October1,2026JPML actions pending report, October1,2026 · court
  5. EMA PRAC meeting highlights June2–5,2025, notice June6,2025EMA PRAC meeting highlights June2–5,2025, notice June6,2025 · regulator
  6. Hathaway et al., semaglutide and NAION, original author abstract and metadataHathaway et al., semaglutide and NAION, original author abstract and metadata · study
  7. MedlinePlus eye careMedlinePlus eye care · regulator
  8. ABA Model Rule1.5: FeesABA Model Rule1.5: Fees
  9. HHS your medical recordsHHS your medical records · regulator
  10. SDNY filing-time FAQSDNY filing-time FAQ · court
  11. U.S.Courts civil case processU.S.Courts civil case process · court
  12. JPML creates the GLP-1 vision-loss MDL — No. 3163jpml.uscourts.gov · Dec 1, 2025 · court
  13. Harvard study in JAMA Ophthalmology links semaglutide to NAIONpubmed.ncbi.nlm.nih.gov · Jul 1, 2024 · study

Want the complete picture?

Read the case guide for eligibility, evidence and your next steps.

View the full GLP-1 drugs, sight loss and possible claims case guide →